1. Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer
   Santanu Maji et al, 2018, CrossRef
2. Suitable parameter choice on quantitative morphology of A549 cell in epithelial–mesenchymal transition
   Zhou-Xin Ren et al, 2015, Bioscience Reports CrossRef
3. MicroRNA-29b-3p reduces cisplatin resistance in non-small cell lung cancer by targeting myeloid cell leukemia-1
   Yuanjun Cheng et al, 2024, Molecular & Cellular Toxicology CrossRef
4. BAMBI overexpression together with β-sitosterol ameliorates NSCLC via inhibiting autophagy and inactivating TGF-β/Smad2/3 pathway
   Xingchun Wang et al, 2017, Oncology Reports CrossRef
5. PB01 suppresses radio-resistance by regulating ATR signaling in human non-small-cell lung cancer cells
   Tae Woo Kim et al, 2021, Scientific Reports CrossRef
6. Copy‐number variation of MCL1 predicts overall survival of non‐small‐cell lung cancer in a Southern Chinese population
   Jieyun Yin et al, 2016, Cancer Medicine CrossRef
7. Cancer cell‑specific anticancer effects of Coptis�chinensis on gefitinib‑resistant lung cancer cells are mediated through the suppression of Mcl‑1 and Bcl‑2
   Jae Hwan Kim et al, 2020, International Journal of Oncology CrossRef
8. PAK1 Is a Novel Therapeutic Target in Tyrosine Kinase Inhibitor–Resistant Lung Adenocarcinoma Activated by the PI3K/AKT Signaling Regardless of EGFR Mutation
   De-Wei Wu et al, 2016, Clinical Cancer Research CrossRef
9. MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1
   Dezhi Cheng et al, 2016, Molecular and Cellular Biochemistry CrossRef
10. Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes
    Tomas Tokar et al, 2018, Oncotarget CrossRef
11. M2‐like tumor‐associated macrophages promote epithelial–mesenchymal transition through the transforming growth factor β/Smad/zinc finger e‐box binding homeobox pathway with increased metastatic potential and tumor cell proliferation in lung squamous cell carcinoma
    Ryota Sumitomo et al, 2023, Cancer Science CrossRef
12. Epithelial‐to‐mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy
    Mau Ern Poh et al, 2019, Thoracic Cancer CrossRef
13. EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation
    Ana Vila et al, 2016, PLOS ONE CrossRef
14. Inhibition of epithelial‐to‐mesenchymal transition augments antitumor efficacy of nanotherapeutics in pancreatic ductal adenocarcinoma
    Kai‐Zhou Jin et al, 2023, The FEBS Journal CrossRef
15. Clinical Impact of the Epithelial-Mesenchymal Transition in Lung Cancer as a Biomarker Assisting in Therapeutic Decisions
    Julien Ancel et al, 2022, Cells Tissues Organs CrossRef
16. Benzophenone-3 increases metastasis potential in lung cancer cells via epithelial to mesenchymal transition
    Preeyaporn Plaimee Phiboonchaiyanan et al, 2017, Cell Biology and Toxicology CrossRef
17. Epithelial Mesenchymal Transition in Embryonic Development, Tissue Repair and Cancer: A Comprehensive Overview
    Do Kim et al, 2017, Journal of Clinical Medicine CrossRef
18. Polypeptide antibiotic actinomycin D induces Mcl-1 uncanonical downregulation in lung cancer cell apoptosis
    Chia-Ling Chen et al, 2023, Life Sciences CrossRef
19. ALI multilayered co-cultures mimic biochemical mechanisms of the cancer cell-fibroblast cross-talk involved in NSCLC MultiDrug Resistance
    Dania Movia et al, 2019, BMC Cancer CrossRef
20. MicroRNA-520c-3p Modulates Doxorubicin-Chemosensitivity in HepG2 Cells
    Mohamed A. Ragheb et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
21. Desmethylclomipramine triggers mitochondrial damage and death in TGF-β-induced mesenchymal type of A549 cells
    Fu-Chia Shih et al, 2024, Life Sciences CrossRef
22. Cancer drug resistance induced by EMT: novel therapeutic strategies
    Javier De Las Rivas et al, 2021, Archives of Toxicology CrossRef
23. A novel cell-based assay for the high-throughput screening of epithelial–mesenchymal transition inhibitors: Identification of approved and investigational drugs that inhibit epithelial–mesenchymal transition
    Hiroyuki Ishikawa et al, 2023, Lung Cancer CrossRef
24. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non–Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion
    Sebastian Marwitz et al, 2016, Cancer Research CrossRef
25. Prospects for new lung cancer treatments that target EMT signaling
    Yuji Otsuki et al, 2018, Developmental Dynamics CrossRef
26. Reserpine inhibits DNA repair, cell proliferation, invasion and induces apoptosis in oral carcinogenesis via modulation of TGF-β signaling
    Arun Kumar Ramu et al, 2021, Life Sciences CrossRef
27. PomGnT1 enhances temozolomide resistance by activating epithelial-mesenchymal transition signaling in glioblastoma
    Qi Liu et al, 2017, Oncology Reports CrossRef
28. Inhibition of Non-Small Cell Lung Cancer Cells by Oxy210, an Oxysterol-Derivative that Antagonizes TGFβ and Hedgehog Signaling
    Frank Stappenbeck et al, 2019, Cells CrossRef
29. Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion
    Adelaide IJ Young et al, 2018, Cell Adhesion & Migration CrossRef
30. The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer
    Kazuya Kuwada et al, 2018, Journal of Experimental & Clinical Cancer Research CrossRef
31. Therapeutic targeting ofTGF‐β in lung cancer
    Sajjad Aftabi et al, 2024, The FEBS Journal CrossRef
32. Sphingosine kinase-2 Inhibitor ABC294640 Enhances Doxorubicin-Induced Apoptosis of NSCLC Cells via Altering Survivin Expression
    Leili Hasanifard et al, 2018, Drug Research CrossRef
33. Rational Combination Therapy for Melanoma with Dinaciclib by Targeting BAK-Dependent Cell Death
    Xiaoou Xu et al, 2020, Molecular Cancer Therapeutics CrossRef